Clinical Trial Update: Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study evaluated raltegravir in HIV/HCV coinfected patients with advanced hepatic cirrhosis (Child-Pugh C) to characterize drug expo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Human Immunodeficiency Virus Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | Conditions: Human Immunodeficiency Virus, Hepatitis C | Phase 1 | Status: COMPLETED